APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dalbavancin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dalbavancin Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchDalbavancin Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dalbavancin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Dalbavancin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dalbavancin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Dalbavancin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Dalbavancin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dalbavancin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dalbavancin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dalbavancin market include Sanofi, Novartis, Merck, Roche, Pfizer, GSK, Amgen, Abbvie and Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dalbavancin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dalbavancin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dalbavancin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dalbavancin market size, projected growth trends, production technologies, key applications, and end-use industries.

Dalbavancin Segment by Company

Sanofi

Novartis

Merck

Roche

Pfizer

GSK

Amgen

Abbvie

Johnson

Hayao

Gilead

Dalbavancin Segment by Type

Intravenous Therapy

Oral Type

Dalbavancin Segment by Application

Skin Infection

Soft Tissue Infection

Others

Dalbavancin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dalbavancin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dalbavancin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dalbavancin significant trends, drivers, influence factors in global and regions.

6. To analyze Dalbavancin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dalbavancin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dalbavancin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dalbavancin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dalbavancin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dalbavancin industry.

Chapter 3: Detailed analysis of Dalbavancin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dalbavancin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dalbavancin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dalbavancin Industry Trends Table 2. Dalbavancin Industry Drivers Table 3. Dalbavancin Industry Opportunities and Challenges Table 4. Dalbavancin Industry Restraints Table 5. Global Dalbavancin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dalbavancin Revenue Share by Company (2021-2026) Table 7. Global Dalbavancin Sales Volume by Company (k units) & (2021-2026) Table 8. Global Dalbavancin Sales Volume Share by Company (2021-2026) Table 9. Global Dalbavancin Average Price (US$/unit) of Company (2021-2026) Table 10. Global Dalbavancin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dalbavancin Key Company Manufacturing Base & Headquarters Table 12. Global Dalbavancin Company, Product Type & Application Table 13. Global Dalbavancin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dalbavancin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intravenous Therapy Table 18. Significant Companies of Oral Type Table 19. Global Dalbavancin Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Dalbavancin Sales Volume by Type (2021-2026) & (k units) Table 21. Global Dalbavancin Sales Volume by Type (2027-2032) & (k units) Table 22. Global Dalbavancin Sales Volume Share by Type (2021-2026) Table 23. Global Dalbavancin Sales Volume Share by Type (2027-2032) Table 24. Global Dalbavancin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dalbavancin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dalbavancin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dalbavancin Sales Value Share by Type (2021-2026) Table 28. Global Dalbavancin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Skin Infection Table 30. Significant Companies of Soft Tissue Infection Table 31. Significant Companies of Others Table 32. Global Dalbavancin Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Dalbavancin Sales Volume by Application (2021-2026) & (k units) Table 34. Global Dalbavancin Sales Volume by Application (2027-2032) & (k units) Table 35. Global Dalbavancin Sales Volume Share by Application (2021-2026) Table 36. Global Dalbavancin Sales Volume Share by Application (2027-2032) Table 37. Global Dalbavancin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dalbavancin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dalbavancin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dalbavancin Sales Value Share by Application (2021-2026) Table 41. Global Dalbavancin Sales Value Share by Application (2027-2032) Table 42. Global Dalbavancin Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Dalbavancin Sales by Region (2021-2026) & (k units) Table 44. Global Dalbavancin Sales Market Share by Region (2021-2026) Table 45. Global Dalbavancin Sales by Region (2027-2032) & (k units) Table 46. Global Dalbavancin Sales Market Share by Region (2027-2032) Table 47. Global Dalbavancin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dalbavancin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dalbavancin Sales Value Share by Region (2021-2026) Table 50. Global Dalbavancin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dalbavancin Sales Value Share by Region (2027-2032) Table 52. Global Dalbavancin Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Dalbavancin Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Dalbavancin Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Dalbavancin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dalbavancin Sales by Country (2021-2026) & (k units) Table 57. Global Dalbavancin Sales Market Share by Country (2021-2026) Table 58. Global Dalbavancin Sales by Country (2027-2032) & (k units) Table 59. Global Dalbavancin Sales Market Share by Country (2027-2032) Table 60. Global Dalbavancin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dalbavancin Sales Value Market Share by Country (2021-2026) Table 62. Global Dalbavancin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dalbavancin Sales Value Market Share by Country (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Sanofi Dalbavancin Product Portfolio Table 68. Sanofi Recent Development Table 69. Novartis Company Information Table 70. Novartis Business Overview Table 71. Novartis Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Novartis Dalbavancin Product Portfolio Table 73. Novartis Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Merck Dalbavancin Product Portfolio Table 78. Merck Recent Development Table 79. Roche Company Information Table 80. Roche Business Overview Table 81. Roche Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Roche Dalbavancin Product Portfolio Table 83. Roche Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Pfizer Dalbavancin Product Portfolio Table 88. Pfizer Recent Development Table 89. GSK Company Information Table 90. GSK Business Overview Table 91. GSK Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. GSK Dalbavancin Product Portfolio Table 93. GSK Recent Development Table 94. Amgen Company Information Table 95. Amgen Business Overview Table 96. Amgen Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Amgen Dalbavancin Product Portfolio Table 98. Amgen Recent Development Table 99. Abbvie Company Information Table 100. Abbvie Business Overview Table 101. Abbvie Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Abbvie Dalbavancin Product Portfolio Table 103. Abbvie Recent Development Table 104. Johnson Company Information Table 105. Johnson Business Overview Table 106. Johnson Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Johnson Dalbavancin Product Portfolio Table 108. Johnson Recent Development Table 109. Hayao Company Information Table 110. Hayao Business Overview Table 111. Hayao Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Hayao Dalbavancin Product Portfolio Table 113. Hayao Recent Development Table 114. Gilead Company Information Table 115. Gilead Business Overview Table 116. Gilead Dalbavancin Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Gilead Dalbavancin Product Portfolio Table 118. Gilead Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Dalbavancin Distributors List Table 122. Dalbavancin Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Dalbavancin Product Image Figure 2. Global Dalbavancin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dalbavancin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dalbavancin Sales (2021-2032) & (k units) Figure 5. Global Dalbavancin Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Dalbavancin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intravenous Therapy Image Figure 10. Oral Type Image Figure 11. Global Dalbavancin Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Dalbavancin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dalbavancin Sales Volume Share by Type (2021-2032) Figure 14. Global Dalbavancin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dalbavancin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dalbavancin Sales Value Share by Type (2021-2032) Figure 17. Skin Infection Image Figure 18. Soft Tissue Infection Image Figure 19. Others Image Figure 20. Global Dalbavancin Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Dalbavancin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dalbavancin Sales Volume Share by Application (2021-2032) Figure 23. Global Dalbavancin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dalbavancin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dalbavancin Sales Value Share by Application (2021-2032) Figure 26. Global Dalbavancin Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Dalbavancin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dalbavancin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dalbavancin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dalbavancin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dalbavancin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dalbavancin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dalbavancin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dalbavancin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dalbavancin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dalbavancin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dalbavancin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dalbavancin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dalbavancin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dalbavancin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dalbavancin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dalbavancin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dalbavancin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dalbavancin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Intravenous Therapy
  • Oral Type
Applications
  • Skin Infection
  • Soft Tissue Infection
  • Others
Companies covered
  • Sanofi
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GSK
  • Amgen
  • Abbvie
  • Johnson
  • Hayao
  • Gilead

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dalbavancin Sales Value (2021-2032)
  4. 1.2.2 Global Dalbavancin Sales Volume (2021-2032)
  5. 1.2.3 Global Dalbavancin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dalbavancin Market Dynamics
  1. 2.1 Dalbavancin Industry Trends
  2. 2.2 Dalbavancin Industry Drivers
  3. 2.3 Dalbavancin Industry Opportunities and Challenges
  4. 2.4 Dalbavancin Industry Restraints
3 Dalbavancin Market by Company
  1. 3.1 Global Dalbavancin Company Revenue Ranking in 2025
  2. 3.2 Global Dalbavancin Revenue by Company (2021-2026)
  3. 3.3 Global Dalbavancin Sales Volume by Company (2021-2026)
  4. 3.4 Global Dalbavancin Average Price by Company (2021-2026)
  5. 3.5 Global Dalbavancin Company Ranking (2024-2026)
  6. 3.6 Global Dalbavancin Company Manufacturing Base and Headquarters
  7. 3.7 Global Dalbavancin Company Product Type and Application
  8. 3.8 Global Dalbavancin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dalbavancin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dalbavancin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dalbavancin Market by Type
  1. 4.1 Dalbavancin Type Introduction
  2. 4.1.1 Intravenous Therapy
  3. 4.1.2 Oral Type
  4. 4.2 Global Dalbavancin Sales Volume by Type
  5. 4.2.1 Global Dalbavancin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dalbavancin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dalbavancin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dalbavancin Sales Value by Type
  9. 4.3.1 Global Dalbavancin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dalbavancin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dalbavancin Sales Value Share by Type (2021-2032)
5 Dalbavancin Market by Application
  1. 5.1 Dalbavancin Application Introduction
  2. 5.1.1 Skin Infection
  3. 5.1.2 Soft Tissue Infection
  4. 5.1.3 Others
  5. 5.2 Global Dalbavancin Sales Volume by Application
  6. 5.2.1 Global Dalbavancin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dalbavancin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dalbavancin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dalbavancin Sales Value by Application
  10. 5.3.1 Global Dalbavancin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dalbavancin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dalbavancin Sales Value Share by Application (2021-2032)
6 Dalbavancin Regional Sales and Value Analysis
  1. 6.1 Global Dalbavancin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dalbavancin Sales by Region (2021-2032)
  3. 6.2.1 Global Dalbavancin Sales by Region: 2021-2026
  4. 6.2.2 Global Dalbavancin Sales by Region (2027-2032)
  5. 6.3 Global Dalbavancin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dalbavancin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dalbavancin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dalbavancin Sales Value by Region (2027-2032)
  9. 6.5 Global Dalbavancin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dalbavancin Sales Value (2021-2032)
  12. 6.6.2 North America Dalbavancin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dalbavancin Sales Value (2021-2032)
  15. 6.7.2 Europe Dalbavancin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dalbavancin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dalbavancin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dalbavancin Sales Value (2021-2032)
  21. 6.9.2 South America Dalbavancin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dalbavancin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dalbavancin Sales Value Share by Country, 2025 VS 2032
7 Dalbavancin Country-level Sales and Value Analysis
  1. 7.1 Global Dalbavancin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dalbavancin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dalbavancin Sales by Country (2021-2032)
  4. 7.3.1 Global Dalbavancin Sales by Country (2021-2026)
  5. 7.3.2 Global Dalbavancin Sales by Country (2027-2032)
  6. 7.4 Global Dalbavancin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dalbavancin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dalbavancin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dalbavancin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dalbavancin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dalbavancin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dalbavancin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dalbavancin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dalbavancin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dalbavancin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dalbavancin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dalbavancin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dalbavancin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dalbavancin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dalbavancin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dalbavancin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dalbavancin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dalbavancin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dalbavancin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dalbavancin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dalbavancin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dalbavancin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dalbavancin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dalbavancin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dalbavancin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dalbavancin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dalbavancin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dalbavancin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dalbavancin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dalbavancin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dalbavancin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dalbavancin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dalbavancin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dalbavancin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dalbavancin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dalbavancin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dalbavancin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dalbavancin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dalbavancin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dalbavancin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dalbavancin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dalbavancin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dalbavancin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dalbavancin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dalbavancin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dalbavancin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dalbavancin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dalbavancin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dalbavancin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dalbavancin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dalbavancin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dalbavancin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dalbavancin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dalbavancin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dalbavancin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dalbavancin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dalbavancin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dalbavancin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dalbavancin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dalbavancin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dalbavancin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dalbavancin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dalbavancin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dalbavancin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dalbavancin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dalbavancin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dalbavancin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dalbavancin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dalbavancin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dalbavancin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dalbavancin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dalbavancin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dalbavancin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dalbavancin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dalbavancin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dalbavancin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dalbavancin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dalbavancin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dalbavancin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dalbavancin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dalbavancin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dalbavancin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dalbavancin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dalbavancin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dalbavancin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dalbavancin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dalbavancin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Dalbavancin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Dalbavancin Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Dalbavancin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Dalbavancin Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Dalbavancin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Dalbavancin Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Dalbavancin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Dalbavancin Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Dalbavancin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Dalbavancin Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Dalbavancin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Dalbavancin Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Amgen
  38. 8.7.1 Amgen Company Information
  39. 8.7.2 Amgen Business Overview
  40. 8.7.3 Amgen Dalbavancin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Amgen Dalbavancin Product Portfolio
  42. 8.7.5 Amgen Recent Developments
  43. 8.8 Abbvie
  44. 8.8.1 Abbvie Company Information
  45. 8.8.2 Abbvie Business Overview
  46. 8.8.3 Abbvie Dalbavancin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Abbvie Dalbavancin Product Portfolio
  48. 8.8.5 Abbvie Recent Developments
  49. 8.9 Johnson
  50. 8.9.1 Johnson Company Information
  51. 8.9.2 Johnson Business Overview
  52. 8.9.3 Johnson Dalbavancin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Johnson Dalbavancin Product Portfolio
  54. 8.9.5 Johnson Recent Developments
  55. 8.10 Hayao
  56. 8.10.1 Hayao Company Information
  57. 8.10.2 Hayao Business Overview
  58. 8.10.3 Hayao Dalbavancin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hayao Dalbavancin Product Portfolio
  60. 8.10.5 Hayao Recent Developments
  61. 8.11 Gilead
  62. 8.11.1 Gilead Company Information
  63. 8.11.2 Gilead Business Overview
  64. 8.11.3 Gilead Dalbavancin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Gilead Dalbavancin Product Portfolio
  66. 8.11.5 Gilead Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dalbavancin Value Chain Analysis
  2. 9.1.1 Dalbavancin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dalbavancin Sales Mode & Process
  6. 9.2 Dalbavancin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dalbavancin Distributors
  9. 9.2.3 Dalbavancin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst